How Eisai V. Sanofi Will Affect Loyalty Discount Cases
On May 4, 2016, the Third Circuit affirmed a summary judgment finding that Sanofi-Aventis U.S. LLC's loyalty discounts for its anticoagulant drug Lovenox were not anti-competitive. In doing so, the court...To view the full article, register now.
Already a subscriber? Click here to view full article